Controlling orthopoxvirus infections - 200 Years after Jenner's revolutionary immunization

Archivum Immunologiae et Therapiae Experimentalis

Volumn 44, Issue 5-6, 1996, Pages 373-378

  Niemiałtowski, Marek G ^a   Toka, Felix N ^a   Malicka, Elzbieta ^a   Gieryńbska, Małgorzata ^a   De Faundez, Irma Spohr ^a   Schollenberger, Ada ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Cellular and humoral immunity; Orthopoxviruses

Indexed keywords

GLYCOPROTEIN; SMALLPOX VACCINE; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN; VIRUS VACCINE;

ANIMAL; CELLULAR IMMUNITY; DISEASE CARRIER; GENETICS; HISTORY; HUMAN; IMMUNOLOGY; ORTHOPOXVIRUS; PHYSIOLOGY; POXVIRUS INFECTION; REVIEW; SMALLPOX; VACCINATION;

ANIMALS; ANTIGENS, VIRAL; DISEASE RESERVOIRS; GLYCOPROTEINS; HISTORY, 18TH CENTURY; HUMANS; IMMUNITY, CELLULAR; ORTHOPOXVIRUS; POXVIRIDAE INFECTIONS; SMALLPOX; SMALLPOX VACCINE; VACCINATION; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 0030340472     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. AHMED R. (1992): Immunological memory against viruses. Sem. Immunol., 4, 105-109.
2. ALCAMI A. and SMITH G. L. (1995): Cytokine receptors encoded by poxviruses: a lesson in cytokine biology. Immunol. Today, 16, 474-478.
3. BAXBY D. (1990): Poxviridae. In: Topley and Wilson's principles of bacteriology, virology and immunology. 8th edition. E. Arnold, London, 4, 559-571.
4. + T cells correlating with cytotoxic activity in vitro are more effecient in antivaccinia virus protection than CD4-dependent IL. J. Immunol., 146, 4301-4307.
5. BLANDEN R. V., KEES U. and DUNLOP M. B. C. (1977): In vitro primary induction of cytotoxic T cells virus-infected syngeneic cells. J. Immunol. Methods, 16, 73-89.
6. BULLER R. M. L., HOLMES K. L., HUGGIN A., FREDERICSON T. N. and MORSE H. C. III (1987): Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature, 327, 77-79.
7. BULLER R. M. L. and PALUMBO G. J. (1991): Poxvirus pathogenesis. Microbiol. Rev., 55, 80-122.
8. CZERNY C. P. and MAHNEL H. (1990): Structural and functional analysis of orthopoxvirus epitopes with neutralizing monoclonal antibodies. J. Gen. Virol., 71, 2341-2352
9. + cytotoxic T lymphocytes in humans. J. Virol., 67, 1538-1544.
10. DEMKOWICZ W. E. JR., LITTAUA R. A., WANG J. and ENNIS F. A. (1996): Human cytotoxic T-cell memory: long-lived responses to vaccinia virus. J. Virol, 70, 2627-2631.
11. DEMKOWICZ W. E. JR., MAA J. S. and ESTEBAN M. (1992): Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans. J. Virol., 66, 386-398.
12. DOHERTY P. C. (1993): Inflammation in virus infections. Sem. Virol., 4, 117-122.
13. ERICKSON A. L. and WALKER C. M. (1993): Class I major histocompatibility complex-restricted cytotoxic T cell responses to vaccinia virus in humans. J. Gen. Virol., 74, 751-754.
14. ESSANI K. and DALES S. (1979): Biogenesis of vaccinia: evidence for more than 100 polypeptides in the virion. Virology, 95, 385-394.
15. FENNER F., WITTEK R. and DUMBELL K. R. (1988): The orthopoxviruses. Academic Press, Inc., San Diego, 85-144.
16. FUJISAWA H. and HEARING P. (1994): Structure, function and specificity of DNA packaging signals in double-stranded DNA viruses. Sem. Virol., 5, 5-13.
17. KOSZINOWSKI U. H., REDDEHASE M. J. and JONJIC S. (1991). The role of CD4 and CD8 T cells in viral infections. Curr. Opin. Immunol., 3, 471-475.
18. KOTWAL G. J., ISAACS S. N. and MOSS B. (1990): Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science, 250, 827-830.
19. + cytotoxic T-lymphocyte clones. J. Virol., 66, 2274-2280.
20. MAUDSLEY D. J. and POUND J. D. (1991): Modulation of MHC antigen expression by viruses and oncogenes. Immunol. Today, 12, 429-431.
21. MCFADDEN G. and GRAHAM K. (1994): Modulation of cytokine networks by poxvirus: the myxoma virus model. Sem. Virol., 5, 421-429.
22. MIYAZAKI I., CHEUNG R. K. and DOSCH H. M. (1994): The role of vIL-10 and other EBV latency genes early during B cell growth transformation. Sem. Virol., 5, 405-414.
23. MURPHY F. A., FAUQUET C. M., BISHOP D. H. L., GHABRIAL S. A., JARVIS A. W., MARTELLI G. P., MAYO M. A. and SUMMERS M. D. (1995): Poxviridae. In: Virus taxonomy, classification and nomenclature of viruses. VIth Report of the International Committee on Taxonomy of Viruses. Springer, Wien - New York, 79-91.
24. 2-M deficient mice. Immunobiology, 190, 183-194.
25. + T cell phenotypes in acute and memory states. Arch. Immunol. Ther. Exp., 42, 319-324.
26. NIEMIAŁTOWSKI M. G., SPOHR DE FAUNDEZ I., GIERYŃSKA M., MALICKA E., TOKA F. N., SCHOLLENBERGER A. and POPIS A. (1994): The inflammatory and immune response to mousepox (infectious ectromeha) virus. Acta Virol., 38, 299-307.
27. O'NEILL H. C. and BRENAN M. (1987): A role for early cytotoxic T cells in resistance to ectromelia virus infection in mice. J. Gen. Virol., 68, 2669-2673.
28. O'ROURKE A. M. and MESCHER M. F. (1993): The roles of CD8 in cytotoxic T lymphocyte function. Immunol. Today, 14, 183-188.
29. PALUMBO G. J. and BULLER R. M. L. (1991): Inhibitors of the lipoxygenase pathway specifically block orthopoxvirus replication. Virology, 180, 457-463.
30. RODRIGUEZ J. F. and ESTEBAN M. (1987): Mapping and nucleotide sequence of the vaccinia virus gene that encodes a 14-kilodalton fusion protein. J. Virol., 61, 3550-3554.
31. SMITH G. L. (1993): Vaccinia virus glycoproteins and immune evasion. J. Gen. Virol., 74, 1725-1740.
32. SMITH G. L. and CHAN Y. S. (1991): Two vaccinia virus proteins structurally related to the interleukin-2 receptor and the immunoglobulin super family. J. Gen. Virol., 72, 511-518.
33. SPOHR DE FAUNDEZ I., GIERYŃSKA M., NIEMIAŁTOWSKI M. G., MALICKA E. and POPIS A. (1995): Ectromelia virus establishes a persistent infection in spleen dendritic cells and macrophages of BALB/c mice following the acute disease. In BANCHEREAU J. and SCHMITT D. (eds.): Dendritic cells in fundamental and clinical immunology. Plenum Press, New York, 2, 257-261.
34. 2+ in ectromelia (mousepox) virus stimulated cytotoxic T lymphocytes. Viral Immunol. (in press).
35. VITETTA E. S., BERTON M. T., BURGER C., KEPRON M., LEE W. T. and YIN X.-M. (1991): Memory B and T cells. Annu. Rev. Immunol., 9, 193-217.
36. WALLACE G. D. and BULLER R. M. L. (1985): Kinetics of ectromelia virus (mousepox) transmission and clinical response in C57BL/6J, BALB/cByJ and AKR/J inbred mice. Lab. Anim. Sci., 35, 41-48.